Treatment of glioblastoma using multicomponent silica nanoparticles

Glioblastomas (GBMs) remain highly lethal. This partially stems from the presence of brain tumor initiating cells (BTICs), a highly plastic cellular subpopulation that is resistant to current therapies. In addition to resistance, the blood-brain barrier limits the penetration of most drugs into GBMs...

詳細記述

保存先:
書誌詳細
出版年:Adv Ther (Weinh)
主要な著者: Turan, O., Bielecki, P.A., Perera, V., Lorkowski, M., Covarrubias, G., Tong, K., Yun, A., Loutrianakis, Georgia, Raghunathan, S., Park, Y., Moon, T., Cooley, S., Dixit, D., Griswold, M.A., Ghaghada, K.B., Peiris, P.M., Rich, J.N., Karathanasis, E.
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7500584/
https://ncbi.nlm.nih.gov/pubmed/32953978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adtp.201900118
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料